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Abstract  
Anxiety disorders (ADs) are nervous system maladies involving changes in the amygdala 
synaptic circuitry, such as an upregulation of excitatory neurotransmission at glutamatergic 
synapses. In the field of nanotechnology, thin graphene oxide flakes with nanoscale lateral size 
(s-GO) have shown outstanding promise for the manipulation of excitatory neuronal 
transmission with high temporal and spatial precision, thus they were considered as ideal 
candidates for modulating amygdalar glutamatergic transmission. Here, we validated an in vitro 
model of amygdala circuitry as a screening tool to target synapses, towards development of 
future ADs treatments. After one week in vitro, dissociated amygdalar neurons reconnected 
forming functional networks, whose development recapitulated that of the tissue of origin. When 
acutely applied to these cultures, s-GO flakes induced a selective modification of excitatory 
activity. This type of interaction between s-GO and amygdalar neurons may form the basis for 
the exploitation of alternative approaches in the treatment of ADs. 
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INTRODUCTION  
Anxiety disorders (ADs), including phobias and post-traumatic stress disorder, comprise 
diseases whose common features are excessive and enduring fear, anxiety or avoidance to 
situations perceived as a threat by the subject.1 These syndromes are the most prevalent type 
of psychiatric illness in western societies2 and have a significant socio-economic burden.3 
Studies, both in patients and in animal models of ADs, have indicated that a potential 
mechanistic explanation for the behavioral expression of these syndromes, can be glutamate 
hyper-activity in excitatory synapses of the amygdala.4–8 
 
Amygdaloid complex is an almond shaped small structure located deeply into the temporal 
lobes of the right and left hemispheres, whose function has been related to the processing of 
emotions, such as fear.9 These structures are composed by clusters of nuclei, uniquely 
connected with other intra-amygdalar bodies or encephalic areas.10 That specific wiring lies at 
the basis of amygdala functionality, which works as a processor receiving sensory and cognitive 
information from the thalamus and cortex and, upon elaboration of these inputs, sends diverse 
outputs to other brain structures, resulting in a range of behavioral/autonomic and endocrine 
responses to various environmental contests.11 The characterization of this complex 
connectivity has been instrumental also in identifying dysfunctional pathways in ADs and new 
therapeutic approaches aimed at manipulating synaptic functions with a high spatial-temporal 
control. To address such demands, innovative and promising tools might emerge from 
nanotechnology developments. 
 
Recently, thin and small (between 100-300 nm in lateral size) graphene oxide flakes (s-GO), a 
type of carbon-based nanomaterial, has been found to interfere selectively with the activity of 
hippocampal glutamatergic synapses.12,13 When delivered in vivo into the hippocampus of 
juvenile rats, this nanomaterial induced a selective, transient and spatially restricted modulation 
of the excitatory synaptic activity.13 The ability of s-GO for high spatial and temporal precision in 
targeting glutamatergic synaptic transmission might be exploited to address the excitatory 
malfunction of the amygdala, underlying ADs. However, to date it is completely unexplored 
whether s-GO exerts effects on the activity of amygdalar neurons. The restricted anatomical 
access to amygdaloid bodies limits specific experimental synaptic studies in vivo, thus, more 
simplified models of amygdala circuitries are needed for fast screening of new drugs, molecules 
and nanomaterials that might have applications for the treatment of ADs. 
 In the current work, we developed an in vitro model of amygdalar neuronal networks, whose 
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activity was explored by patch clamp recordings. We show that after one week in vitro neurons 
reconnected, forming active synapses, whose characteristics underwent to a process of 
maturation, resembling those occurring in vivo. The acute treatment with s-GO of these cultures 
strongly modulated glutamatergic signaling, indicating that the nanomaterial interacted with 
amygdalar neurons at the level of excitatory synapses. Thus, we validated this alternative in 
vitro model of amygdala for studying the effect of innovative nano-sized tools for the therapy of 
ADs. 
 
MATERIALS AND METHODS 
Graphene oxide nanosheet synthesis and characterisation  
Graphene oxide (GO) sheets of small lateral dimensions were synthesized using a modified 
Hummers method. All materials used were produced under endotoxin-free conditions, and 
yielded single to few-layer sheets with identical surface chemistry and thickness. The s-GO was 
constituted mostly of nanometre-sized sheets between 50 nm and 2 μm. A detailed description 
for the preparation and characterization of this nanomaterial can be found elsewhere.12,13 
 
Dissociated amygdalar cultures 
Isolation of rat brains was performed in agreement with the Italian law (decree 26/14) and the 
European Union (EU) guidelines (2007/526/CE and  2010/63/UE) and all the procedures were 
authorized by the local veterinary authorities and by the institutional (ISAS) ethical committee. 
The animal use was approved by the Italian Ministry of Health.  
 
Primary cultures of amygdalar cells were obtained from Wistar rats aged 8-10 days. Brains were 
quickly removed from the skull and placed in fresh ice-cold artificial cerebrospinal fluid (ACSF) 
whose composition was (in mM):  124 NaCl, 24 NaHCO3, 13  glucose, 5 HEPES, 2.5 KCl, 2 
CaCl2, 2 MgSO4 and 1,2  NaPO4H2 with a pH of 7.3-7.4 when saturated with 95% O2 and 5% 
CO2.
14  
 
Coronal brain slices (400 μm) including the amygdala complex were cut using a vibratome 
(Leica VT100S) and transferred into a dish containing ice-cold oxygenated ACSF. Under a 
dissecting microscope (Olympus SZ40), the regions containing the amygdalar nuclei were 
isolated using a biopsy punch with a dimeter of 1 mm (Kai Medical, Japan). The collected tissue 
was enzymatically and mechanically dissociated following standard protocol.15 Cells were 
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seeded onto poly-L-ornithine-coated glass coverslips at a density of 800 cells/mm2 and 
maintained in controlled conditions (at 37 °C, 5% CO2) for 8-12 days.  
 
Immunofluorescence  
Cultures were fixed after 8 or 12 days in vitro (DIV) with 4% paraformaldehyde in PBS for 20 
minutes and adding 1% glutaraldehyde in PBS for 1 hour for GABA staining as previously 
reported.16 Cells were permeabilized with Triton X-100 (0.3 %), incubated for 30 minutes at 
room temperature (RT) with primary antibodies and, after being rinsed with PBS, incubated with 
secondary antibodies for 30 min at RT. As primary antibodies, we used mouse monoclonal anti-
GFAP antibody (Sigma G3893, 1:500 dilution) and rabbit polyclonal anti- β-tubulin III antibody 
(Sigma T2200, 1:500 dilution) to label glial cells and neurons respectively.12 GABAergic neurons 
were co-stained with mouse monoclonal anti- β-tubulin III antibody (Sigma T8535, 1:500 
dilution) and anti-GABA polyclonal antibody produced in rabbit (Sigma A2052, 1:300 dilution17). 
As secondary antibodies, we employed Alexa 594 goat anti-rabbit (Invitrogen, 1:500 dilution), 
Alexa 594 goat anti-mouse (Invitrogen, 1:500 dilution), Alexa 488 goat anti-mouse (Invitrogen, 
1:500 dilution) and Alexa 488 goat anti-rabbit (Invitrogen, 1:500 dilution). Nuclei were marked 
with DAPI (1:400, Invitrogen). For each sample, images of 5 randomly selected fields were 
acquired using a confocal microscope (Nikon Eclipse Ti, Nikon, Japan). Images from three 
different culture series were analyzed with the software ImageJ (NIH). 
 
Electrophysiology 
Patch clamp whole-cell recordings were performed from neurons using glass micropipettes with 
a resistance of 4 ÷ 7 MΩ when filled with the intracellular saline solution composed of (mM): 120 
K gluconate, 20 KCl, 10 HEPES, 10 EGTA, 2 MgCl2, 2 Na2ATP, pH 7.3 and osmolarity 300 
mOsm. All experiments were performed at room temperature from cells continuously perfused 
at 5 ml/min with the standard extracellular solution containing (mM): 150 NaCl, 4 KCl, 2 CaCl2, 1 
MgCl2, 10 HEPES, 10 glucose, pH 7.4. All data were recorded by means of a Multiclamp 700B 
patch amplifier (Axon CNS, Molecular Devices) digitized at 10 KHz by pClamp 10 software 
(Molecular Devices LLC, USA). Input resistance and cells capacitance were measured online 
with the membrane test feature of the pClamp software. Spontaneous activity was recorded in 
voltage clamp mode at a holding potential of -56 mV (not corrected for the liquid junction 
potential which was -14 mV).  
Spontaneous postsynaptic currents (PSCs) were analyzed offline using the software AxoGraph 
X (Axograph Scientific), which exploits a detection algorithm based on a sliding template. For 
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each recording, all the collected events were averaged and the peak amplitude and kinetic 
properties of the mean current were calculated. The decay time of PSCs was calculated by 
fitting the decaying phase of the current with a mono-exponential function. Templates 
characterized by diverse decay times were used to separate offline glutamate AMPA-receptor 
mediated PSCs (~3 ms) and those mediated by GABAA -receptors (~20 ms).  
 
Pairs of monosynaptically connected neurons, in which the cells were apart ~100 µm one from 
the other, were recognized by the short latency 2.9 ± 0.3 ms12,18 between the peak of the 
presynaptic neuron and the onset of the evoked PSC (ePSC). Using a Picospritzer (PDES-
02DX; NPI electronic GmbH, Germany), an injection of pressurized air (500 ms, 0.5 PSI) was 
exploited to deliver a puff of s-GO to the amygdalar neurons. The puff pipette was filled with 
standard saline solution (control) or with s-GO (100 µg/ml diluted in saline solution) and located 
at a distance of about 200 μm from the recorded cell. Considering 1 ml of extracellular solutions 
in our recording chamber, we estimated that the concentration of s-GO reaching the patch-
clamped neurons was at least 10% of that present in the puff pipette as previously reported.12,13 
PSCs were recorded before (10 min, baseline) and after (5 min) the local ejection.  
 
Statistical Analysis 
All values from samples subjected to the same experimental protocols were pooled together 
and expressed as mean ± s.e.m. with n = number of neurons, if not otherwise indicated. 
D'Agostino & Pearson omnibus normality test was applied to evaluate the statistical distribution 
of the data sets. Statistically significant difference between two data sets was assessed by 
Student’s t-test or by Mann–Whitney test. Statistical significance was determined at P < 0.05. 
 
RESULTS 
To explore the impact of nanomaterials on amygdalar circuitry, in particular on subcellular 
components, such as synapses, we developed a simplified in vitro model of amygdala. This 
structure was isolated with a high degree of precision from coronal brain slices using a biopsy 
punch. The collected region underwent a process of enzymatic digestion (see Materials and 
Methods), then cells were seeded on peptide-covered glass coverslips and allowed to develop 
for 8-12 DIV. In parallel, the slices from which the amygdalar complexes were isolated were 
processed with Nissl staining, to assess brain structures and confirm the correct anatomical 
Journal Pre-proof
Jo
urn
al 
Pr
e-p
roo
f
sampling of amygdalae (Figure 1A). 
 
The maturation of amygdalar cultures in vitro was characterized through immunofluorescence 
technique and confocal microscopy. Fixed preparations were immunostained for neuronal and 
glial markers at two different time points of their development (8 and 12 DIV) to measure culture 
size and cell composition (Figure 1B-E). Neurons were labelled with antibodies against the 
specific cytoskeletal components β-tubulin III (in red) and against glial fibrillary acidic protein 
(GFAP, in green) to visualize glial cells. Nuclei were marked with DAPI (in blue). As shown by 
the z-stack reconstructions in Figure 1B, glial cell density remained stable between 8 and 12 
DIV (at 8 DIV: 110.6 ± 7.8 cells/mm2 and at 12 DIV:  98.0 ± 5.3 GFAP positive cells/mm2; n = 30 
visual fields each condition), while neuronal density decreased along with the culture aging (at 8 
DIV:  80.3 ± 4.8 cells/mm2 and at 12 DIV: 64.2 ± 4.3 cells/mm2; P = 0.0131, Figure 1B-C).  We 
further explored the neuronal composition of our cultures by determining the amount of 
inhibitory neurons. To this aim, we co-immunostained cells with antibodies against β-tubulin III 
(in red) and GABA (in light blue, Figure 1D).  
 
The amount of double positive cells, identified as GABAergic neurons, was not changed 
between 8 and 12 DIV (42 % and 40 % respectively, n = 30 visual fields for each conditions, 
Figure 1E). Thus, dissociated amygdalar cultures appeared healthy and formed by well-
differentiated GFAP-positive cells and different neuronal phenotypes. Their composition 
appeared stable over time with the exception for a slight, but statistically significant reduction in 
the number of neurons in older cultures. 
 
Next, we tested amygdalar circuit activity in vitro by patch clamp recording of basal synaptic 
activity (voltage clamp mode) from single cells which were used as probes to sense inputs 
received by surrounding neurons. Figure 1F shows exemplificative recordings from neurons at 
8 and 12 DIV, in which the current deflections correspond to spontaneous PSCs (sPSCs). 
sPSCs frequencies were slightly larger, although not significantly, in older cultures (8 DIV: 1.5 ± 
0.3 Hz, n = 21; 12 DIV: 2.4 ± 0.4 Hz, n = 41; Figure 1G), while PSCs amplitudes increased in 
older cultures (from 20 ± 1 pA 8 DIV to 30 ± 2 pA 12 DIV; Figure 1H). Such statistically 
significant difference (P = 0.0003) is in agreement with the presence of more mature synapses 
at the end of the second week in vitro. 
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In amygdalar cultures, spontaneous synaptic activity was composed by a mixed population of 
fast (~3 ms) and slow (~20 ms) decaying sPSCs. The former were abolished by the application 
of CNQX (10 µM), an antagonist of glutamate AMPA receptor mediated currents (n = 6), while 
the latter were blocked by treatment with gabazine (10 µM), a GABAA receptor antagonist (n = 
3). Their kinetic properties together with their pharmacology supports their excitatory 
glutamatergic (EPSCs; fast decaying events) or inhibitory GABAergic (IPSCs; slow decaying 
events) nature. 
 
The diverse decay times of EPSCs and IPSCs were exploited to isolate them offline (see 
methods). Figure 2A displays examples of fast decaying excitatory and slow decaying inhibitory 
sPSCs, collected from the traces of Figure 1F. The analysis of the EPSCs and IPSCs revealed 
small changes in their frequencies during the maturation of the cultures (EPSCs from 1.1 ± 0.3 
Hz to 2.1 ± 0.4 Hz; IPSCs from 0.4 ± 0.1 Hz to 0.3 ± 0.1 Hz, 8 and 12 DIV, respectively; Figure 
2B). However, the amplitudes of both EPSCs and IPSCs resulted enhanced in a statistically 
significant manner in older cultures in respect to younger ones (EPSCs from 17 ± 1 pA to 22 ± 1 
pA, 8 and 12 DIV, respectively P = 0.008; IPSCs: from 25 ± 3 pA to 39 ± 3 pA, 8 and 12 DIV, 
respectively, P = 0.005; Figure 2C). When analyzing the kinetic properties of IPSCs and EPSCs 
separately, we found that the rise and decay times of EPSCs both increased during neuronal 
growth (rise time: from  0.72 ± 0.02 ms to 1.02 ± 0.04 ms, from 8 and 12 DIV, respectively, P < 
0.0001; decay time: from 2.64 ± 0.16 ms to 3.64 ± 0.18 ms, 8 and 12 DIV, respectively, P = 
0.0042). Conversely, while also the IPSCs rise time became longer (from 1.37 ± 0.07 ms to 2.05 
± 0.05 ms, 8 and 12 DIV, P < 0.0001), their decay time resulted faster in older cells (from 21.10 
± 1.31 ms to 17.31 ± 0.88 ms, 8 and 12 DIV, P < 0.0001; Figure 2D). All together these findings 
indicated that both the excitatory and inhibitory components of the network mature during the 
second week of differentiation in vitro. 
 
With the exception of IPSCs decay time, all sPSCs kinetic parameters slowed down during 
neuronal growth, a result in accordance with an increase in the electrotonic filtering of neurites 
(e.g. longer neurites), following dimensional growth of single neurons. Indeed, cell capacitance, 
an indirect measure of neuronal size,19 of more mature neurons was increased in respect to 
younger cultures (from 52 ± 3 pF to 61 ± 3 pF, n = 30 and n = 55, 8 and 12 DIV respectively, P = 
0.031), while the input resistance (from 398 ± 36 MΩ to 413 ± 28 MΩ, 8 and 12 DIV, Figure 2E) 
and the resting membrane potential (from -59 ± 2 mV to -63 ± 1 mV, 8 and 12 DIV, Figure 2F) 
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were similar at the two time points measured. 
 
In a further set of experiments, we induced in current clamp mode action potentials (APs) by 
injecting neurons with short square pulses of depolarizing currents (Figure 2G). The analysis of 
AP amplitudes (at 8 DIV: 98 ± 4 mV, n = 14, and 12 DIV: 102 ± 2 mV, n = 47) and half-widths (at 
8 DIV: 3.0 ± 0.2 ms 12 DIV: 3.0 ± 0.2 ms) detected no differences between the two culture 
groups (Figure 2 G-I), suggesting that APs were already mature after one week of growth in 
vitro. 
 
We further investigated synaptic connectivity at 12 DIV by dual patch clamp recordings from 
pairs of mono-synaptically connected neurons (Figure 3A): the presynaptic cell was elicited to 
fire APs in current clamp configuration, while the postsynaptic one was simultaneously clamped 
at -56 mV to monitor the presence of an ePSC (Figure 3B, see methods). The probability to find 
monosynaptically connected pairs of neurons was high (75%, n = 36 pairs, Figure 3C), 
indicating an elevated degree of connectivity in the neuronal network. In addition, the analysis of 
ePSCs kinetic features revealed that the majority (93%, n = 29, Figure 3D) of synapses 
activated slow decaying currents (~ 20 ms), identifiable as GABAA mediated IPSCs, while only a 
subset of these (7%) showed fast ePSCs (~3 ms), compatible with AMPA receptor mediated 
EPSCs (Figure 3B). The short-term plasticity of these synapses, evaluated by a pair of stimuli 
at 20 Hz (see methods), revealed that both excitatory and inhibitory connections underwent to 
short-term depression of ePSCs (ratios between the amplitude of the second and first ePSCs 
were 0.9 ± 0.1 for the excitatory connections and 0.7 ± 0.1 for the inhibitory ones; Figure 3B). 
Overall, our electrophysiological characterization showed that after 8 DIV, dissociated 
amygdalar neurons reconnected forming functional synapses, whose activity was further 
modified during the second week of development in vitro, compatibly with the acquisition of a 
more mature phenotype of the culture. We decided to exploit such simplified model to test the 
interaction of s-GO with amygdalar neurons. 
 
In the last set of experiments, we tested whether s-GO affected synaptic activity as showed 
before for hippocampal culture.12,13 In mature cultures (12 DIV), a puff of solution containing s-
GO (or saline as control) was pressure-applied through a pipette located at a distance of 200 
μm from a neuron, while its spontaneous activity was monitored in voltage clamp mode (Figure 
4A). Figure 4B shows that s-GO application (orange arrow) produced a change in neuronal 
activity, while the treatment with saline (black arrow) exerted no effect. Magnifications of the 
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traces before and after the puffs (insets in the bottom row of Figure 4B) display that s-GO 
induced changes in the frequency but not in the amplitude of sPSCs. A quantification of these 
parameters detected a statistically significant increment in the after puffs frequencies of sPSCs 
between saline (n = 12) and s-GO (n = 12) treated neurons (for saline-treated: 2.5 ± 0.5 Hz and 
for s-GO-treated: 5.5 ± 1.1 Hz, P = 0.0447; Figure 4C), while the pre-puffs frequencies were 
similar between the two treatments (for saline-treated: 2.6 ± 0.5 Hz and for s-GO-treated: 4.2 ± 
1.0 Hz; Figure 4C). No changes were detected in the amplitudes of sPSCs due to s-GO 
application (pre-puff values were 65 ± 16 pA for saline and 66 ± 13 pA for s-GO; post-puff 
values were 57 ± 13 pA for saline and 48 ± 6 pA for s-GO; Figure 4D). 
  
To better point out the effect of s-GO, we normalized the post-puff values for the pre-puff ones 
for each cell (Figure 4E). Thus, we observed a change of 78.8% ± 36.5% in sPSCs frequency 
after the puff in s-GO treated neurons (P = 0.0424), on the opposite in saline treated cells this 
difference was not statistically relevant (-1.5% ± 5.0%; Figure 4E). By isolating the excitatory 
and the inhibitory components of the network by means of offline analysis, we detected that s-
GO induced modifications only in the frequency of EPSCs (for saline treated neurons: -0.4% ± 
7.3%, and for s-GO treated ones: 130% ± 65.3%, P = 0.0255  pre vs post in s-GO treated 
samples;  P = 0.0292 saline vs s-GO; Figure 4F), while that of IPSCs was unchanged (12.1% ± 
14.3%, for saline treated and 15.2% ± 19.5%, for s-GO treated; Figure 4G). These results 
showed that this nanomaterial was able to interfere with the function of amygdalar neurons, by 
upregulating specifically the activity of excitatory synapses. 
 
 
DISCUSSION 
In the current work, we studied the interaction of thin s-GO flakes with amygdalar neurons, 
showing that this material can modulate selectively the excitatory glutamatergic transmission in 
neuronal circuits obtained from that brain region. We developed dissociated cultures from the 
amygdalae to better dissect synaptic activity at the single cell level.20,21 With respect to previous 
works,14,22–25 we improved our preparation in terms of purity, due to a more precise procedure to 
explant amygdalae, confirmed by our Nissl staining. Cultured amygdalar circuits developed with 
a slight decrease in neurons during the second week in vitro, commonly observed in culture,26 
possibly related to a reduced availability of neurotrophic factors in respect to the in vivo 
condition.27–29 However, despite the slight decline in the number of neurons, synaptic circuits 
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seems to mature progressively, as indicated by the enhancement in the amplitude of both 
EPSCs and IPSCs at 12 DIV. 
 
Also, the kinetic properties of sPSCs changed during this time window: rise times of EPSCs and 
IPSCs slowed down, while decay times got slower for EPSCs and faster for IPSCs. These 
trends match with those observed in amygdala explants obtained from animals at different 
ages,30 indicating that in our model, neurons retraced a process of physiological maturation. 
While the speed-up of IPSCs decay time is compatible with a developmental switch from the α2- 
to the α1-subunit of GABAA receptors,
31 the slowing down of the other kinetic properties  may be 
in part related to electrotonic filtering due to the growth of neurons during the maturation. Longer 
dendrites, indeed, would result in slower kinetic properties of sPSCs.32 In agreement with this 
hypothesis, an increase in cell capacitance, an indicator of neuronal dimension, was observed 
at 12 DIV.19 Conversely, we did not detect changes either in the properties of APs or in the 
resting membrane potentials, both reported similar to those of juvenile amygdalar neurons in 
vivo.33 This confirms that our cultures present characteristics of mature amygdalar cells, with 
synapses undergoing a progressive strengthening when re-constructing active contacts in 
vitro.34,35 
 
The latter observation was reinforced by the high connectivity detected by dual patch clamp 
recordings at 12 DIV: to note, the large majority of synaptic connections were GABAergic. This 
might appear controversial respect to the characterization of spontaneous network activity, 
where the frequency of EPSCs was prevalent when compared to that of IPSCs. The higher 
probability to find inhibitory synapses was possibly related to our experimental setting (dual 
recordings from neurons apart 100 µm one to the other), which would favor the selection of 
interneurons.15 
 
The contribution of amygdala in shaping behavioural responses to environmental stimuli is 
developmentally regulated,36,37 with complex fear responses consolidating around the third 
postnatal week.38–40 Our electrophysiological characterization showed that, when the tissue of 
origin is collected from juvenile animals (P8-P10) and cells are allowed to differentiate in vitro for 
8-12 days, cultures have single cell and synaptic features resembling those of in vivo amygdalar 
neurons of adolescent animals. Thus, we developed an easily accessible, simplified model of 
mature amygdala for the study of neuronal circuits, suited for fast screening of new 
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drugs/materials/devices. 
 
We used this system to show that s-GO could modify the synaptic function of amygdalar 
neurons. In fact, we reported that when acutely applied, the nanomaterial induced an 
enhancement in network activity, measured as an increase in the frequency of sPSCs in 
comparison to the pre-treatment baseline. Such effect was selective for the glutamatergic 
synapses, since s-GO changed the occurrence of EPSCs, but not that of IPSCs. s-GO exert 
their effect modifying the presynaptic release of the neurotransmitter.12,13 In other brain regions, 
the prolonged exposure to this nanomaterial resulted in the depletion of glutamate from 
presynaptic terminals, responsible for a decrease in the activity of excitatory synapses.12,13 
Since ADs are characterized by a glutamate mediated hyper-function of the amygdala,4,7,41,42 s-
GO might be exploited as therapeutics for long term impairing of glutamate release, ultimately 
down-regulating specifically this pathologically potentiated excitatory signaling. 
 
Further experiments will be required to demonstrate that the increase in EPSC frequency 
reported here after s-GO application is only a transient effect and that, upon prolonged 
application, the nanomaterial is effective in reducing amygdalar activity. If the high spatial and 
temporal precision demonstrated by s-GO in downregulating excitatory signaling in other brain 
regions will be preserved in the amygdala, this nanomaterial might be a powerful alternative tool 
for the modulation of selective glutamatergic circuits whose activity is aberrant in ADs. 
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FIGURES  
 
FIGURE 1: Dissociated amygdalar neurons reconstruct functional networks in vitro 
(A) Schematic representation of dissociated amygdalar culture procedure: brains isolated from 
juvenile rats are sliced (left); amygdaloid nuclei are precisely isolated by a biopsy punch (in 
green) and enzymatically dissociated to get pure cultures (right). The remaining tissue is stained 
with Nissl procedure (middle) to confirm the sampling of the amygdalae. (B) Confocal images of 
cultures at 8 (left) and 12 (right) DIV, stained with β tubulin III (in red), GFAP (in green) and 
DAPI for nuclei (in blue). (C) Bar plots summarizing the neuron (left) and glial (right) cell 
densities at 8 and 12 DIV. Note the decrease in neuronal density in cultures at 12 DIV. (D) 
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Confocal images of neurons double stained with β tubulin III (in red) and GABA (in light blue) at 
8 and 12 DIV. (E) Bar plots summarize the percentage of GABAergic neurons (double-positive 
cells) at the two time points. (F). On the top, representation of patch clamp recording from single 
cell. Below, exemplificative traces of spontaneous network activity recorded from amygdalar 
neurons after 8 and 12 DIV. Bar plots showing the frequency (G) and the amplitude (H) of 
sPSCs at 8 and 12 DIV.  
In all bar plots, dots superimposed to the bars are single values and * P < 0.05.  
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FIGURE 2: Electrophysiological characterization of amygdalar neurons 
(A) Offline PSCs analysis of fast-EPSCs (left) and slow-IPSCs (right) at 8 and 12 DIV. Bar plots 
showing the frequencies (B) and the amplitudes (C) of EPSCs and IPSCs at the two considered 
temporal points. The amplitudes of both the types of currents are increased in more mature 
cultures. (D) Summary graphs of EPSC and IPSC kinetic properties at 8 (black circle) and 12 
(blue square) DIV. (E) Summary graph of input resistance and cell capacitance at 8 (black 
circle) and 12 (blue square) DIV. Capacitance becomes larger in more mature neurons. (F) Bar 
plots summarizing the neuronal resting membrane potential at the two temporal points. (G) 
Representative traces of action potentials in neurons at 8 (black) and 12 (blue) DIV neurons, 
elicited by current injection (the protocol is shown below). Bar plots summarizing the AP 
amplitudes (H) and half-width (I) in the two conditions.  
In all bar plots dots superimposed to the bars are single values and * P < 0.05. 
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FIGURE 3: Electrophysiological characterization of unitary postsynaptic currents at 12 
DIV 
(A) Sketch of the experimental setting for pair recordings. (B) Currents injections (above, 4 ms, 
1 nA@20Hz) elicit action potentials in the presynaptic neuron (middle). Below, representative 
averaged traces of evoked unitary EPSCs or IPSCs recorded from postsynaptic neurons. (C) 
Bar plot summarizing the percentage of monosynaptically coupled pairs at 12 DIV. (D) 
Histograms showing the percentage of different type of connections in monosynaptically 
coupled pairs.  
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FIGURE 4: Acute application of s-GO interferes with glutamatergic activity of amygdalar 
neurons (A) Sketch of the experimental setting. (B) Top, representative traces of the 
spontaneous synaptic activity during acute application of saline (left) or s-GO (right). Arrows 
represent the puff ejection (see methods). Bottom, magnified traces of the spontaneous 
synaptic activity recorded before and after saline (left) and s-GO (right) applications. Box plots 
summarize the sPSC frequency (C) and amplitude (D) before and after the acute application of 
saline (black) and s-GO (orange). sPSCs frequency is increased only by treatment with s-GO. 
Summary graphs of the change in sPSCs (E), sEPSCs(F) and sIPSCs (G) frequency after the 
saline (black circle) and s-GO (orange square) puff. s-GO affect selectively the frequency of 
EPSCs. * P < 0.05.  
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Graphical Abstract: text  
Thin graphene oxide with small lateral size (s-GO), a nanomaterial able to modulate the activity 
of excitatory synapses, holds great potential as therapeutic for the treatment of neuro-
pathologies in which glutamatergic transmission is altered. An example of these are anxiety 
disorders, characterized by excessive excitatory activity in the amygdala.  In the current study, 
after implementing and characterizing a simplified in vitro model of amygdala, we verified that s-
GO succeeded in modulating the activity of amygdalar excitatory synapses. This is a proof-of-
concept that s-GO might be used for the treatment of anxiety disorders. 
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